Please use this identifier to cite or link to this item:
Type: Journal article
Title: Weight loss using meal replacements high in glycomacropeptide-enriched whey powder
Author: Keogh, J.
Clifton, P.
Citation: Australian Journal of Dairy Technology, 2009; 64(1):32-33
Publisher: Dairy Industry Assn Australia
Issue Date: 2009
ISSN: 0004-9433
Statement of
J.B. Keogh and P.M. Clifton
Abstract: Cholecystokinin (CCK) is a peptide hormone that causes gallbladder contraction and pancreatic enzyme secretion for the digestion of protein and fat. It is also thought to have a role in satiety. It has been reported that glycomacropeptide (GMP) stimulates the release of CCK and may contribute to increased satiety and reduced energy intake. The aim of this study was to examine after six months whether greater weight loss could be achieved with a GMP-enriched whey powder meal replacement compared to a skim milk protein powder meal replacement. In a randomised, double blind, parallel design, body composition measured by dual-energy X-ray absorptiometry (DEXA) and cardiovascular disease (CVD) risk factors were measured at baseline and 6 months. The weight loss strategy used meal replacements (MR) containing 33 g protein from GMP-enriched-whey-protein-isolate, or skim-milk-protein-powder (SMPP) and 954kJ kJ/sachet. Volunteers were asked to consume 2 MR/day instead of 2 meals for 6 months. One hundred and twenty seven participants (34 men, 99 women, 95.5± 15.4 kg, BMI 33.4±3.4 kg/m2, 50.0± 12.4 yr) commenced and 82 completed the 6 month study. After 6 months weight loss was 9.5±5.8 vs 11.0±6.0 kg, GMP and SMPP respectively (p<0.001 compared with baseline) with no differences between treatments. Total and LDL-cholesterol, triglycerides, glucose, insulin, systolic and diastolic blood pressure decreased at 6 months (All p<0.01 compared with baseline with no difference between treatments). We conclude that weight loss using dairy protein-based meal replacements achieved a clinically meaningful weight loss with benefics on markers of CVD risk but GMP had no additional effect using this study design.
Description (link):
Published version:
Appears in Collections:Aurora harvest 5
Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.